BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maziade PJ, Ship N, Sniffen JC, Goldstein EJC. Enhanced Clostridioides difficile infection prevention with a pharmacy-controlled policy that adds a three-strain Lactobacillus probiotic concomitantly to antibiotic therapy. Clin Infect Dis 2021:ciab414. [PMID: 33966076 DOI: 10.1093/cid/ciab414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Heil E, Harris A, Leekha S. Reply to McFarland et al. Clin Infect Dis 2021:ciab619. [PMID: 34240136 DOI: 10.1093/cid/ciab619] [Reference Citation Analysis]
2 Baus CJ, Schulz LT, Lepak AJ, Safdar N. Letter to the Editor: Response to Maziade et al; Enhanced Clostridioides difficile infection prevention with a pharmacy-controlled policy that adds a three-strain Lactobacillus probiotic concomitantly to antibiotic therapy. Clin Infect Dis 2021:ciab661. [PMID: 34320158 DOI: 10.1093/cid/ciab661] [Reference Citation Analysis]
3 Pal R, Athamneh AIM, Deshpande R, Ramirez JAR, Adu KT, Muthuirulan P, Pawar S, Biazzo M, Apidianakis Y, Sundekilde UK, de la Fuente-nunez C, Martens MG, Tegos GP, Seleem MN. Probiotics: insights and new opportunities for Clostridioides difficile intervention. Critical Reviews in Microbiology. [DOI: 10.1080/1040841x.2022.2072705] [Reference Citation Analysis]